{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T10:37:19Z","timestamp":1770547039761,"version":"3.49.0"},"reference-count":28,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2005,11,22]],"date-time":"2005-11-22T00:00:00Z","timestamp":1132617600000},"content-version":"vor","delay-in-days":11467,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arthritis &amp; Rheumatism"],"published-print":{"date-parts":[[1974,7]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In 10 patients with Wegener's granulomatosis, low doses of cyclophosphamide produced: severe lymphocytopenia of long duration even after therapy ceased; a greater percentage decrease in nonrosette forming lymphocytes than in rosette forming T\u2010lymphocytes; normal in vitro lymphocyte responses to mitogens (PHA, ConA, and PWM) with suppressed responses to one of two antigens tested (SK\u2010SD). This regimen did not cause severe granulocytopenia and was successful in inducing and maintaining long\u2010term clinical remissions.<\/jats:p>","DOI":"10.1002\/art.1780170404","type":"journal-article","created":{"date-parts":[[2007,2,14]],"date-time":"2007-02-14T16:30:38Z","timestamp":1171470638000},"page":"355-361","source":"Crossref","is-referenced-by-count":34,"title":["Cyclophosphamide and lymphocyte subpopulations in Wegener's granulomatosis"],"prefix":"10.1002","volume":"17","author":[{"given":"Anthony S.","family":"Fauci","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Dale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sheldon M.","family":"Wolff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2005,11,22]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"365","article-title":"Chemical suppression of the immune response","volume":"15","author":"Hitchings GH","year":"1963","journal-title":"Pharmacol Rev"},{"key":"e_1_2_1_3_2","first-page":"246","article-title":"Immunosuppressive drugs","volume":"9","author":"Schwartz RS","year":"1965","journal-title":"Prog Allergy"},{"key":"e_1_2_1_4_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-75-2-165"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160204"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197010222831701"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160203"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-76-4-619"},{"key":"e_1_2_1_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(54)90255-7"},{"key":"e_1_2_1_10_2","first-page":"533","article-title":"Wegener's granulomatosis: pathology and review of the literature","volume":"58","author":"Godman GC","year":"1954","journal-title":"Arch Pathol"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197104292841703"},{"key":"e_1_2_1_12_2","first-page":"28a","article-title":"Treatment of Wegener's granulomatosis with cyclophosphamide","volume":"50","author":"Fauci AS","year":"1971","journal-title":"J Clin Invest"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197311000-00002"},{"key":"e_1_2_1_14_2","first-page":"77","article-title":"Isolation of mononuclear cells and granulocytes from human blood","volume":"21","author":"B\u00f6yum A","year":"1968","journal-title":"Scand J Clin Lab Invest"},{"key":"e_1_2_1_15_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.136.2.207"},{"key":"e_1_2_1_16_2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4049\/jimmunol.108.1.1","article-title":"Functional heterogeneity of murine lymphoid cells. I. Responsiveness to and surface binding of concanavalin A and phytohemagglutinin","volume":"108","author":"Stobo JD","year":"1972","journal-title":"J Immunol"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780130604"},{"key":"e_1_2_1_18_2","first-page":"506","article-title":"Mechanisms of immunosuppression: effects of cyclophosphamide on lymphocytes","volume":"80","author":"Winklestein A","year":"1972","journal-title":"J Lab Clin Med"},{"key":"e_1_2_1_19_2","first-page":"444","article-title":"Comparative immunosuppressive effects of azathioprine and cyclophosphamide in the treatment of rheumatoid arthritis","volume":"15","author":"Levy J","year":"1972","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160106"},{"key":"e_1_2_1_21_2","first-page":"980a","article-title":"Selective depletion of human circulating B\u2010lymphocytes by cyclophosphamide","volume":"32","author":"Horwitz DA","year":"1973","journal-title":"Fed Proc"},{"key":"e_1_2_1_22_2","first-page":"285","article-title":"Selective depletion of lymphoid tissue by cyclophosphamide","volume":"10","author":"Turk JL","year":"1972","journal-title":"Clin Exp Immunol"},{"key":"e_1_2_1_23_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4049\/jimmunol.110.1.277","article-title":"Differential effects of cyclophosphamide on the B and T cell compartments of adult mice","volume":"110","author":"Stockman GD","year":"1973","journal-title":"J Immunol"},{"key":"e_1_2_1_24_2","first-page":"576","article-title":"Selective suppression of T or B cell responses in man","volume":"21","author":"Dwyer JM","year":"1973","journal-title":"Clin Res"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197112302852701"},{"key":"e_1_2_1_26_2","first-page":"21","article-title":"Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man","volume":"27","author":"Oppenheim JJ","year":"1968","journal-title":"Fed Proc"},{"key":"e_1_2_1_27_2","doi-asserted-by":"crossref","first-page":"262","DOI":"10.4049\/jimmunol.101.2.262","article-title":"The transformation of column\u2010purified lymphocytes with nonspecific and specific antigenic stimuli","volume":"101","author":"Oppenheim JJ","year":"1968","journal-title":"J Immunol"},{"key":"e_1_2_1_28_2","first-page":"442","article-title":"Parameters of improvement in patients with rheumatoid arthritis treated with cyclophosphamide","volume":"15","author":"Hurd ER","year":"1973","journal-title":"Arthritis Rheum"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780160510"}],"container-title":["Arthritis &amp; Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fart.1780170404","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/art.1780170404","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T23:55:55Z","timestamp":1700697355000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/art.1780170404"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1974,7]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1974,7]]}},"alternative-id":["10.1002\/art.1780170404"],"URL":"https:\/\/doi.org\/10.1002\/art.1780170404","archive":["Portico"],"relation":{},"ISSN":["0004-3591","1529-0131"],"issn-type":[{"value":"0004-3591","type":"print"},{"value":"1529-0131","type":"electronic"}],"subject":[],"published":{"date-parts":[[1974,7]]}}}